David Stump

David Stump

Director/Miembro de la Junta en MACROGENICS, INC. .

Fortuna: 263 676 $ al 31/05/2026

76 años
Health Technology
Consumer Services
Health Services

Perfil

David C.
Stump
is an Independent Director at REGENXBIO, Inc. since 2015 and at MacroGenics, Inc. since 2013.
Dr. Stump serves as a Trustee at Earlham College.
Former roles include Independent Director at Dendreon Corp.
from 2011 to 2015, Independent Director at Sunesis Pharmaceuticals, Inc. from 2006 to 2021, Independent Director at Portola Pharmaceuticals LLC from 2015 to 2020, Vice President-Clinical Research at Genentech, Inc. from 1989 to 1999, Executive Vice President-Research & Development at Human Genome Sciences, Inc. from 2007 to 2012, Associate Professor at the University of Vermont, and Trustee at Adventist HealthCare, Inc. from 2000 to 2012.
Education includes undergraduate studies at Earlham College and a doctorate from Indiana University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
29/05/2026 28.861 ( 0,06 % ) 202 316 $ 31/05/2026
19/05/2026 14.750 ( 0,02 % ) 61 360 $ 31/05/2026

Cargos activos de David Stump

EmpresasCargoInicio
MACROGENICS, INC. Director/Miembro de la Junta 19/09/2013
REGENXBIO INC. Director/Miembro de la Junta 15/10/2015
Director/Miembro de la Junta 22/02/2010

Antiguos cargos conocidos de David Stump.

EmpresasCargoFin
VIRACTA THERAPEUTICS, INC. Director/Miembro de la Junta 24/02/2021
PORTOLA PHARMACEUTICALS, INC. Director/Miembro de la Junta 01/07/2020
DENDREON CORPORATION Director/Miembro de la Junta 10/06/2015
Director Técnico/Científico/I+D 01/12/2012
Director/Miembro de la Junta -
Ver el detalle de la experiencia de David Stump.

Formación de David Stump.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

62

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Services